Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleHaploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies
- Where
- St Louis
- Age
- Up to 30 years
- People
- 50
- Run by
- Washington University School of Medicine
See details and how to joinNCT05011422 - Phase 2Taking peopleCaloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Where
- Ann Arbor, Atlanta, Charlotte, Chicago, Cincinnati, Dallas, Denver, Houston, Kansas City, Los Angeles, Minneapolis, Orange, Philadelphia, Portland, Salt Lake City, San Francisco
- Age
- 7 years to 25 years
- People
- 240
- Run by
- Etan Orgel
See details and how to joinNCT05082519 - Phase 1/2Taking peopleA Study of CTD402 in T-ALL/LBL Patients
- Where
- Chicago, Denver, Houston, Nashville, New York, Palo Alto, Rochester, The Bronx
- Age
- 1 year and over
- People
- 118 worldwide
- Run by
- Imviva Bio
See details and how to joinNCT07070219 - No phaseTaking peopleMachine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
- Where
- Victor
- People
- 92
- Run by
- University of Rochester
See details and how to joinNCT07682831 - No phaseNot yet taking people in United StatesBedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury
- Where
- Richmond
- Age
- 2 years to 17 years
- People
- 220
- Run by
- Virginia Commonwealth University
See details and how to joinNCT07772323 - No phaseTaking peopleTwo-photon Fluorescence Microscopy of Dermatologic Biopsies
- Where
- Victor
- People
- 644
- Run by
- University of Rochester
See details and how to joinNCT07773688 - No phaseTaking peopleTriple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
- Where
- Hays, Kansas City, Lee's Summit, Overland Park, Salina, Westwood
- People
- 3,000
- Run by
- University of Kansas Medical Center
See details and how to joinNCT02302742 - Early phase 1Taking peopleChemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
- Where
- Birmingham, Columbus, Grand Rapids, Orange, San Francisco, Valhalla
- Age
- 1 year to 31 years
- People
- 40
- Run by
- New York Medical College
See details and how to joinNCT03719105 - Phase 1Taking peopleTrametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Where
- Baltimore, Birmingham, Boston, Chicago, Dallas, Gainesville, Hackensack, Indianapolis, Los Angeles, Minneapolis, New York, Philadelphia, Portland, San Diego, San Francisco, St Louis, Washington D.C.
- Age
- 1 year to 25 years
- People
- 50
- Run by
- University of California, San Francisco
See details and how to joinNCT04485559 - No phaseTaking peopleWater Vapor Ablation for Prostate Cancer: Long-Term Registry
- Where
- Bossier City, San Antonio, Virginia Beach, Woodbury
- People
- 2,500
- Run by
- Francis Medical Inc.
See details and how to joinNCT07455058 - No phaseTaking peopleInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
- Where
- Boston
- People
- 5,000
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT05463796 - Phase 2Taking peopleAcupuncture for People Experiencing Period Loss Due to Chemotherapy
- Where
- Basking Ridge, Commack, East White Plains, Middletown, Montvale, New York, Rockville Centre
- Age
- 15 years to 40 years
- People
- 60
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06915116 - No phaseTaking peopleRevealing Information Genuinely & Honestly Across Time - Communication Preferences Visit
- Where
- Memphis
- Age
- 12 years and over
- People
- 85
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06993688 - No phaseTaking peopleThe Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
- Where
- Springfield
- People
- 10,000
- Run by
- Appendix Cancer Pseudomyxoma Peritonei Research Foundation
See details and how to joinNCT07769346 - Phase 1Taking peopleMulti-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
- Where
- Baltimore, Washington D.C.
- Age
- 6 months to 80 years
- People
- 50
- Run by
- Catherine Bollard
See details and how to joinNCT02203903 - Phase 1Enrolling by invitationGPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
- Where
- Philadelphia
- Age
- 1 year and over
- People
- 45
- Run by
- Stephan Grupp MD PhD
See details and how to joinNCT05650749 - No phaseTaking peopleSafety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Where
- Boston, Chicago, Cincinnati, Fountain Valley, Houston, Los Angeles, Nashville, Oklahoma City, San Antonio, Seattle
- Age
- 1 day to 17 years
- People
- 40
- Run by
- Fresenius Kabi
See details and how to joinNCT06274788 - Phase 2Taking peopleA Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
- Where
- Austin, Beverly Hills, Chicago, Dallas, Duarte, Durham, Fairfax, Grand Rapids, Houston, Los Angeles, Nashville, New Haven, New York, Palo Alto, San Antonio, St. Petersburg, West Valley City
- Age
- 12 years and over
- People
- 100 worldwide
- Run by
- AbbVie
See details and how to joinNCT07196644 · EU 2024-518871-74-00 - No phaseEnrolling by invitationPathogenesis of Hematologic Malignancies
- Where
- Portland
- Age
- 1 year and over
- People
- 5,000
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT01728402 - No phaseTaking peopleEvaluation of Pediatric eCART Implementation
- Where
- Madison
- Age
- Up to 17 years
- People
- 30,000
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT06771830 - Phase 1Taking peopleSelective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
- Where
- Washington D.C.
- Age
- 1 year to 23 years
- People
- 18
- Run by
- Children's National Research Institute
See details and how to joinNCT07172958 - Phase 2Taking peopleDFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Where
- Austin, Charleston, Charlotte, Chicago, Durham, Hackensack, Hartford, Hershey, Honolulu, Kansas City, Lexington, Little Rock, Louisville, Miami, Oakland, Oklahoma City, Orlando, Portland, Providence, Sacramento, San Diego, Stanford, St Louis, St. Petersburg, Tampa
- Age
- Up to 21 years
- People
- 118 worldwide
- Run by
- Giselle Sholler
See details and how to joinNCT04696029 - Phase 2Taking peopleNaxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Where
- Augusta, Austin, Birmingham, Charleston, Charlotte, Durham, Gainesville, Hartford, Hershey, Honolulu, Little Rock, Louisville, Miami, Minneapolis, Oakland, Orlando, Portland, Richmond, San Diego, St Louis, Winston-Salem
- Age
- 12 months to 21 years
- People
- 93 worldwide
- Run by
- Giselle Sholler
See details and how to joinNCT05489887 · EU 2025-524140-35-00 - No phaseTaking peopleMedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
- Where
- Buffalo
- People
- 150
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06323044 - Phase 1Taking peopleVenetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
- Where
- Houston
- Age
- 12 years to 30 years
- People
- 18
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07513129